Also with strong growth for all of 2016 year over year according to the CEO in the preliminary guidance. I for one think they could blow away the street in 2016, and a PE of 20-25 going forward is warranted for the super growth.
This stock has been a real eye opener. I looked up on Google, and there are articles on how often stocks rally strongly after positive phase 3. You kow how often ? Just about every time- except not with KERX !
Biotech index up over 10% in the last week, while KERX is flat during that same period, even after positive phase lll study results for IDA - unreal !
I looked up phase 2 and found out that Hgb levels rose by .6g/dl, while in phase 3 they rose by 1g/dl. So a 66% further increase in Hgb levels for chronic use you'd think would have rallied the stock a good bit.
Phase 3 study showed this. Just trying to understand why no rally on positive phase 3 results.
No one else has a pill that could replace IV iron. KERX says market is 1.5M just in the US ! Auryxia has found a home !
KERX has estimated 1.5M potential users who are now on IV rion. Stock should pop on positive phase lll studies for the exanded use of Auryxia for Iron Deficient Anemia. News supposed to come early in second qtr. Well second qtr begins Friday !